Pioneering Bariatric Surgeon Zhang Xinguo Appointed to Wuwei Cancer Hospital's Hepato-Pancreato-Biliary Team

Wuwei Cancer Hospital (Gansu Wuwei Academy of Medical and Science ) today announced that Professor Zhang Xinguo, a leading figure in the field of metabolic surgery in China, has officially joined the Hepatobiliary and Pancreatic Surgery Department II of our hospital's Hepatobiliary Center as a clinical and academic support professor. This move marks a significant step forward for Wuwei Cancer Hospital in the surgical treatment of metabolic diseases, bringing cutting-edge diagnostic and treatment options to patients with obesity, type 2 diabetes, and other metabolic disorders in the Northwest region.

Renowned Expert Joins to Advance Metabolic Surgery to New Heights

Professor Zhang Xinguo is a pioneer in metabolic surgery for diabetes treatment in China, boasting over 40 years of clinical experience and having performed more than 20,000 metabolic surgeries both domestically and internationally. He previously served as the Director of General Surgery at the Third Medical Center of the PLA General Hospital and is a core member of the Endocrine Surgery Group of the Chinese Medical Association. He has received 9 national science and technology progress awards, was awarded the Second-Class Merit twice, and enjoys the Special Government Allowance from the State Council. As the "First Person in China to Treat Diabetes with Surgery," he was the first in China to introduce gastric bypass surgery for type 2 diabetes, achieving a clinical cure rate of over 85% within 5 years post-surgery, significantly reducing the risk of diabetes complications.

Technological Advancement: The Evolution from Open Surgery to Minimally Invasive Innovation

After joining, Professor Zhang Xinguo will focus on promoting the standardized implementation of minimally invasive metabolic surgeries such as laparoscopic jejunoileal bypass at Wuwei Cancer Hospital. These procedures adjust the intestinal pathway to stimulate the secretion of incretin hormones like GLP-1, restoring insulin sensitivity and achieving long-term stable blood sugar control. Compared to traditional medical treatments, the surgery offers the following advantages:  

Significant efficacy: Most patients can reduce or eliminate medication dependence after surgery, with some early-stage patients achieving "clinical remission" of diabetes;  

Minimal trauma: Laparoscopic techniques require only 1-3 small incisions, with surgery lasting 45 minutes and patients able to resume activities within 1-2 days, reducing recovery time by 50%;  

Long-term benefits: Lower risk of cardiovascular disease, kidney disease, and other complications, improving quality of life.

Case Study: Metabolic Surgery Revolutionizes Diabetes Management

Case 1: Mr. Zhang, a 40-year-old from Wuwei, had suffered from diabetes for 10 years with severely fluctuating blood sugar levels despite long-term medication. Under the guidance of Professor Zhang Xinguo, he underwent laparoscopic jejunoileal bypass surgery in 2023. His blood sugar returned to normal within 3 days after surgery, and he stopped all hypoglycemic medications after 1 month, maintaining stable blood sugar levels between 5.6-6.8mmol/L to this day.  

Case 2: Ms. Wen, a 36-year-old from Beijing weighing 100 kilograms, suffered from diabetes complicated by hypertension. Her blood sugar normalized within 2 days after surgery, her blood pressure returned to normal after 1 week, and she lost 18 kilograms in 3 months. Her fasting blood sugar dropped from 22mmol/L to 5.2mmol/L.

Institutional Excellence: Establishing the Northwest Metabolic Disease Diagnosis and Treatment Center of Excellence

The Hepatobiliary Center and Hepatobiliary Surgery Department II of Wuwei Cancer Hospital are key disciplines in Gansu Province and Wuwei City, equipped with state-of-the-art facilities such as Siemens 3.0T MRI and dynamic 500-slice gemstone spectral CT, and have performed over 2,000 hepatobiliary and pancreatic surgeries. After Professor Zhang joins, the department will integrate multidisciplinary treatment (MDT) models, collaborating with endocrinology and nutrition departments to provide comprehensive perioperative management from preoperative assessment to postoperative rehabilitation. Currently, the hospital has launched a specialized outpatient clinic for metabolic surgery, with Professor Zhang available for online consultations every Tuesday and Thursday morning. Patients can make appointments through the following channels:  

WeChat appointment:  

Follow the "Gansu Wuwei Cancer Hospital" official account, click "Appointment Registration"-"Hepatobiliary Center-Hepatobiliary Surgery Department II (Heavy Ion Center)";  

On-site registration:  

Outpatient Surgery Area 126A, First Floor, Outpatient Building, China's Heavy Ion Health Town, Ronghua Avenue, Liangzhou District, Wuwei City, Gansu Province;  

Outpatient Clinic 322, Central Hospital Campus, Wuwei Cancer Hospital, Liangzhou District, Wuwei City, Gansu Province.

Clinical Indications for Metabolic Surgery: Evidence-Based Patient Selection

Type 2 diabetes patients: disease duration ≤25 years, residual pancreatic function, BMI ≥25kg/m² (obese) or BMI 23-25kg/m² (non-obese but poorly controlled with medication);  

Obesity patients: BMI ≥27.5kg/m², with complications such as hyperlipidemia or sleep apnea;  

Other metabolic disorders: such as severe fatty liver or polycystic ovary syndrome.

Public Welfare Activity: The first 20 patients will receive special subsidies

To benefit more patients, Wuwei Cancer Hospital has partnered with Professor Zhang Xinguo's team to launch a public welfare program for metabolic surgery. The first 10 patients who schedule surgery before June 10, 2025, can apply (the surgery will be personally performed by Professor Zhang Xinguo):  

● 50% discount on expert surgery fees (for the first 10 patients);  

● Free expert outpatient consultation (for the first 20 patients);  

Address:  

   Wuwei Cancer Hospital Heavy Ion Campus - Hepatobiliary Center - Hepatobiliary and Pancreatic Surgery Department II  

   No. 2 Building, China Heavy Ion Tumor Rehabilitation Town, Ronghua Avenue, Liangzhou District, Wuwei City, Gansu Province (2nd floor, Hepatobiliary Center)  

Wuwei Cancer Hospital Central Campus (Urban Area):  

   Chief Physician Zhang Wenhua's Outpatient Clinic: 2nd Floor, Room 218 (Monday and Wednesday mornings, excluding holidays)  

   Hepatobiliary and Pancreatic Surgery Department II Outpatient Clinic: 3rd Floor, Room 322  

   Hepatology Inpatient Clinic: 2nd Floor, Rooms 216 and 217  

Heavy Ion Campus:  

   Heavy Ion Rehabilitation Town Outpatient Clinic: 1st Floor, Surgical Consultation Area, Room 126A

  Chief Physician Zhang Wenhua's Outpatient Clinic: 2nd Building, Hepatobiliary Center, 3rd Floor, Room 2331 (Tuesday morning, excluding holidays)  

   Hepatology Inpatient Clinic: 2nd Floor, Rooms W210 and W211

Conclusion

Metabolic surgery, known as the "sixth pillar" of diabetes treatment, is bringing hope to countless patients by potentially reversing the disease. With the addition of Professor Zhang Xinguo, the Hepatobiliary Center and Hepatobiliary Surgery Department II of Wuwei Cancer Hospital are set to become a benchmark for metabolic disease diagnosis and treatment in Northwest China. If you or your loved ones are struggling with obesity or diabetes, come visit our hospital for consultation - let medical science rewrite your health future!